Vaccine News and Research

Latest Vaccine News and Research

Fully vaccinated children reduce risk of hospitalization associated with influenza by 54%

Fully vaccinating children reduces the risk of hospitalization associated with influenza by 54%, according to a study by researchers at the University of Michigan, the Clalit Research Institute, and Ben-Gurion University in Israel.

22 Jan 2020

Researchers develop novel technology to produce cheaper, longer-lasting vaccines

A new method to produce vaccines that have a longer shelf-life, are cheaper and can be stored without the need for cooling is being presented in the open access journal BMC Biotechnology.

21 Jan 2020

George Mason University researchers receive $314,000 to design better vaccines

George Mason University's Aarthi Narayanan, Associate Professor, College of Science and the National Center for Biodefense and Infectious Disease, and Remi Veneziano, Assistant Professor, Volgenau School of Engineering, received $314,000 from U.S. Army Medical Research Acquisition Activity for a project researching DNA-nanoparticles and vaccine design.

21 Jan 2020

Study links use of acid reflux drugs with poorer concentration, memory in breast cancer survivors

Acid reflux drugs that are sometimes recommended to ease stomach problems during cancer treatment may have an unintended side effect: impairment of breast cancer survivors' memory and concentration.

17 Jan 2020

Sepsis killing more people than earlier thought

According to a new study published in the latest issue of The Lancet, this week, more people across the globe are dying of sepsis than earlier believed. A team from the University of Pittsburgh and University of Washington schools of medicine led the research along with their colleagues from different disciplines.

16 Jan 2020

NHS partners with pharma giant to trial a twice-a-year jab to lower cholesterol levels

Cardiovascular disease, including heart disease and stroke, are among the top killers worldwide. Ischemic heart disease and stroke are the world’s major killers, accounting for 15.2 million deaths in 2016. A high triglyceride level, combined with high low-density lipoprotein (LDL) cholesterol, is linked to atherosclerosis, which increases the risk for heart attack and stroke.

16 Jan 2020

Sepsis deaths found to be much higher than previously estimated

Twice as many people as previously believed are dying of sepsis worldwide, according to an analysis published today in The Lancet and announced at the Critical Care Reviews annual meeting in Belfast. Among them are a disproportionately high number of children in poor areas.

16 Jan 2020

New whooping cough vaccine needed to protect from emerging superbug strains

Australia needs a new whooping cough vaccine to ensure our most vulnerable are protected from the emergence of superbug strains, new UNSW research has shown.

16 Jan 2020

Twice as many people as previously thought are dying from sepsis, says new report

A new analysis presented at the Critical Care Reviews annual meeting in Belfast, has found that the number of people dying from sepsis worldwide is twice as high as previously estimated.

16 Jan 2020

Survey finds US adults see vaccines as less important than they did in 2001

A new survey reveals that US parents are increasingly opting to not vaccinate their children, with support for vaccines down 10% since 2001 and the concern that they may cause autism, still being a major factor preventing adults from trusting vaccinations.

15 Jan 2020

Biomaterial-based vaccine has potential to completely eliminate AML cells

Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherapy has been the standard AML treatment for over 40 years, and while it often causes the cancer to go into remission, it rarely completely eliminates the cancerous cells, which then lead to disease recurrence in nearly half of treated patients.

14 Jan 2020

Important things you need to know about seasonal flu

Seasonal flu is a serious illness causing approximately 200,000 hospitalizations and 36,000 deaths each year. Federal health officials are reporting that the 2019-2020 flu season could be the worst in decades.

13 Jan 2020

Sida continues to support IVI’s mission to accelerate vaccine research

The International Vaccine Institute, a Seoul, Korea-based international organization, announced today that the Swedish International Cooperation Agency will continue to support IVI's mission to accelerate vaccine research and development for global health with a total contribution of SEK 50 million (approximately 5.24 million USD) over the next five years as part of a longstanding partnership between the Swedish government and IVI.

13 Jan 2020

Rejuvenating the BCG Vaccine

A new primate study published in the journal Nature in January 2020, reports that the almost century-old BCG vaccine against tuberculosis, may be used differently to achieve better protection against lung tuberculosis. While more work remains to be carried out before the findings can be accepted as the basis for clinical practice, they are extremely promising in the fight against this killer.

10 Jan 2020

Sodium chloride nanoparticles offer potential for cancer therapies with fewer side effects

A new study at the University of Georgia has found a way to attack cancer cells that is potentially less harmful to the patient. Sodium chloride nanoparticles – more commonly known as salt – are toxic to cancer cells and offer the potential for therapies that have fewer negative side effects than current treatments.

9 Jan 2020

UMSOM research shows even milder cases of diarrheal diseases can lead to child mortality

Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age.

9 Jan 2020

Nano-sized copper compounds together with immunotherapy can kill cancer cells

An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.

9 Jan 2020